TR200703565T1 - Peroral uygulanabilir antimikrobiyal kompozisyon. - Google Patents

Peroral uygulanabilir antimikrobiyal kompozisyon.

Info

Publication number
TR200703565T1
TR200703565T1 TR2007/03565T TR200703565T TR200703565T1 TR 200703565 T1 TR200703565 T1 TR 200703565T1 TR 2007/03565 T TR2007/03565 T TR 2007/03565T TR 200703565 T TR200703565 T TR 200703565T TR 200703565 T1 TR200703565 T1 TR 200703565T1
Authority
TR
Turkey
Prior art keywords
antimicrobial composition
peroral
composition
lactulose
applicable
Prior art date
Application number
TR2007/03565T
Other languages
English (en)
Inventor
Nikolai Kiselev Alexandrovich
Sergeevich Chicherin Dmitry
Original Assignee
Nikolai Kiselev Alexandrovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200703565(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nikolai Kiselev Alexandrovich filed Critical Nikolai Kiselev Alexandrovich
Publication of TR200703565T1 publication Critical patent/TR200703565T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Buluş, ilaç, kimyasal ve farmasötik sanayii, özellikle de antibiyotik preparatif formlar ile ilgilidir. Yenilik getiren antimikrobiyal kompozisyon, 1:1-1:100 aktif bileşen oranında linosamitler, geniş yelpazede penisilinler, sefalosporinler, makrolitler, tetrasilinler ve laktüloz içeren gruptan seçilen bir antibiyotik içerir. Laktülozun ortalama partikül ebadı 100 nm ila 200 ?m arasında değişir. Adı geçen kompozisyon aynı zamanda katı bir hale ve bir şurup yahut süspansiyon formuna sokulmuş olabilir. Uygulanabilir olduğu yerde, kompozisyon içersine farmasötik olarak kabul edilebilir eksipiyanlar öyle şekilde ilave edilir ki peroral uygulama için kabul edilebilir bir form alır.
TR2007/03565T 2004-08-30 2005-08-25 Peroral uygulanabilir antimikrobiyal kompozisyon. TR200703565T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения

Publications (1)

Publication Number Publication Date
TR200703565T1 true TR200703565T1 (tr) 2007-08-21

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2007/03565T TR200703565T1 (tr) 2004-08-30 2005-08-25 Peroral uygulanabilir antimikrobiyal kompozisyon.

Country Status (21)

Country Link
US (1) US8231871B2 (tr)
EP (1) EP1790357B1 (tr)
JP (1) JP5062480B2 (tr)
CN (1) CN101031321B (tr)
AT (1) ATE410185T1 (tr)
AU (1) AU2005280704B2 (tr)
BR (1) BRPI0514708A (tr)
CA (1) CA2620919C (tr)
DE (1) DE602005010280D1 (tr)
DK (1) DK1790357T3 (tr)
EA (1) EA200700357A1 (tr)
ES (1) ES2314708T3 (tr)
MX (1) MX2007002291A (tr)
NZ (1) NZ554212A (tr)
PL (1) PL1790357T3 (tr)
PT (1) PT1790357E (tr)
RU (1) RU2284832C2 (tr)
TR (1) TR200703565T1 (tr)
UA (1) UA85608C2 (tr)
WO (1) WO2006025767A2 (tr)
ZA (1) ZA200704449B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ544826A (en) 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
SG158869A1 (en) * 2005-01-21 2010-02-26 Warner Chilcott Co Llc A tetracycline metal complex in a solid dosage form
HUE028690T2 (en) 2008-03-18 2016-12-28 Dikovskiy Aleksander Vladimirovich Antibiotic and prebiotic pharmaceutical composition for antibacterial therapy to prevent and treat dysbiosis
CN101998859B (zh) * 2008-03-18 2014-03-05 亚历山大·弗拉基米罗维奇·季科夫斯基 用于预防与抗生素肠道给药相关的生态失调的药物组合物
JP6472788B2 (ja) 2013-05-07 2019-02-20 マイクロニクス， インコーポレイテッド 粘土鉱物およびアルカリ性溶液を使用して核酸含有試料を調製するための方法
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
IE68841B1 (en) * 1988-03-18 1996-07-10 Duphar Int Res Method of preparing solid lactulose
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
AU689250B2 (en) * 1994-04-22 1998-03-26 Astellas Pharma Inc. Colon-specific drug release system
JP2000516222A (ja) * 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング 嚥下が容易な経口医薬組成物
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
AU772633B2 (en) * 1999-03-03 2004-05-06 Eli Lilly And Company Echinocandin/carbohydrate complexes
EP1184038B1 (en) * 1999-06-09 2005-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract

Also Published As

Publication number Publication date
EP1790357A4 (en) 2007-11-07
DK1790357T3 (da) 2009-02-02
WO2006025767A2 (fr) 2006-03-09
JP2008511622A (ja) 2008-04-17
BRPI0514708A (pt) 2008-06-24
CN101031321A (zh) 2007-09-05
NZ554212A (en) 2009-08-28
EP1790357A2 (en) 2007-05-30
ZA200704449B (en) 2008-08-27
EP1790357B1 (en) 2008-10-08
DE602005010280D1 (de) 2008-11-20
WO2006025767A3 (fr) 2006-08-17
US8231871B2 (en) 2012-07-31
ES2314708T3 (es) 2009-03-16
CA2620919C (en) 2014-10-14
EA010199B1 (ru) 2008-06-30
RU2004126203A (ru) 2006-02-10
WO2006025767A8 (fr) 2007-04-05
EA200700357A1 (ru) 2008-06-30
PT1790357E (pt) 2008-12-31
CN101031321B (zh) 2010-12-15
MX2007002291A (es) 2008-02-12
CA2620919A1 (en) 2006-03-09
ATE410185T1 (de) 2008-10-15
AU2005280704B2 (en) 2010-10-07
JP5062480B2 (ja) 2012-10-31
UA85608C2 (ru) 2009-02-10
RU2284832C2 (ru) 2006-10-10
AU2005280704A1 (en) 2006-03-09
US20070254023A1 (en) 2007-11-01
PL1790357T3 (pl) 2009-03-31

Similar Documents

Publication Publication Date Title
TR200703565T1 (tr) Peroral uygulanabilir antimikrobiyal kompozisyon.
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
WO2007070677A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
BR0008059A (pt) Composições de valdecoxib
HRP20100372T1 (hr) Farmaceutski sastavi neuroaktivnog steroida i njihova uporaba
WO2006021160A8 (en) Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
WO2007150075A3 (en) Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
WO2005041934A3 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
MA29744B1 (fr) Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree
HUP0302622A2 (hu) Ellenőrzött hatóanyag-leadású, biológiailag lebontható mikrorészecskék, amelyek csökkentett molekulatömegű, tisztított amilopektinalapú keményítőt tartalmaznak
CA2326048A1 (en) Peroral active agent suspension
WO2003053399A3 (en) Methods for wet granulating azithromycin
BR0111868A (pt) Composições farmacêuticas
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
WO2002064132A3 (en) Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
NO20062668L (no) Orale formuleringer av desoxypeganin og anvendelser derav
WO2007124700A3 (en) Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
WO2007011958A3 (en) Intraoral dosage forms of glucagon
WO2002096354A3 (en) Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
WO2003039437A3 (de) Oral verabreichbare pharmazeutische zubereitung umfassend liposo mal verkapseltes taxol
BG103958A (en) Pharmaceutical compositions of thioxanide and nitazoxanide
WO2007128495A3 (en) Solid pharmaceutical composition of gabapentin
WO2007037790A3 (en) Modified release famciclovir compositions